LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wang Y, Zhou XY, Lu XY, et al. Involvement of the circular RNA/microRNA/glucose-6-phosphate dehydrogenase axis in the pathological mechanism of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20:530–4.
Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156:361–81.
Sun T, Sun BC, Zhao XL, et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology. 2011;54:1690–706.
Sun T, Zhao N, Zhao XL, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51:545–56.
Guzman G, Cotler SJ, Lin AY, et al. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med. 2007;131:1776–81.
Shao B, Zhao X, Liu T, et al. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma. J Cell Mol Med. 2019;23:1363–74.
Li X, Sun B, Zhao X, et al. Function of BMP4 in the Formation of vasculogenic mimicry in hepatocellular carcinoma. J Cancer. 2020;11:2560–71.
Engreitz JM, Pandya-Jones A, McDonel P, et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science. 2013;341:1237973.
Kanduri C. Long noncoding RNAs: lessons from genomic imprinting. Biochem Biophys Acta. 2016;1859:102–11.
Ard R, Tong P, Allshire RC. Long non-coding RNA-mediated transcriptional interference of a permease gene confers drug tolerance in fission yeast. Nat Commun. 2014;5:5576.
Li Y, Wang Z, Shi H, et al. HBXIP and LSD1 Scaffolded by lncrna hotair mediate transcriptional activation by c-myc. Can Res. 2016;76:293–304.
Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors prc2, lsd1, and dnmt1. Can Res. 2016;76:6299–310.
Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647–58.
Huan L, Liang LH, He XH. Role of microRNAs in inflammation-associated liver cancer. Cancer Biol Med. 2016;13:407–25.
Hu W, Wang T, Yang Y, et al. CPuORF correlates with miRNA responsive elements on protein evolutionary rates. Biochem Biophys Res Commun. 2014;452:66–71.
Xiao M, Li J, Li W, et al. MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. 2017;14:1326–34.
Uva P, Cossu-Rocca P, Loi F, et al. miRNA-135b contributes to triple negative breast cancer molecular heterogeneity: different expression profile in basal-like versus non-basal-like phenotypes. Int J Med Sci. 2018;15:536–48.
Huang V, Place RF, Portnoy V, et al. Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012;40:1695–707.
Chen S, Deng X, Sheng H, et al. Noncoding RNAs in pediatric brain tumors: molecular functions and pathological implications. Mol ther Nucl acids. 2021;26:417–31.
Zhou H, Jia X, Yang F, et al. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2’-5’-oligoadenylate synthetase 2 axis in acute myeloid leukemia. Bioengineered. 2021;12:6403–17.
Yin Y, Yang W, Zhang L, et al. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma. Hematology. 2021;26:160–9.
Jiang G, Yu H, Li Z, et al. lncRNA cytoskeleton regulator reduces nonsmall cell lung cancer radiosensitivity by downregulating miRNA206 and activating prothymosin alpha. Int J Oncol. 2021;59:88.
Raei N, Safaralizadeh R, Hesseinpourfeizi M, et al. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance. Life Sci. 2021;284: 119933.
Babaei G, Raei N, Toofani Milani A, et al. The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis. Mol Biol Rep. 2021;48:6935–47.
Mirzaei S, Saebfar H, Gholami MH, et al. MicroRNAs regulating SOX2 in cancer progression and therapy response. Expert Rev Mol Med. 2021;23: e13.
Crudele F, Bianchi N, Astolfi A, et al. The Molecular Networks of microRNAs and their targets in the drug resistance of colon carcinoma. Cancers. 2021;13:4355.
Zhao X, Sun B, Liu T, et al. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma. Cancer Sci. 2018;109:3197–208.
Wang Y, Sun H, Zhang D, et al. TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer. J Cell Mol Med. 2018;22:3475–88.
Sun B, Zhang D, Zhao N, et al. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Oncotarget. 2017;8:30502–10.
Hendrix MJ, Seftor EA, Meltzer PS, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA. 2001;98:8018–23.
Li W, Zong S, Shi Q, et al. Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin. Sci Rep. 2016;6:37534.
Bai J, Yeh S, Qiu X, et al. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals. Oncogene. 2018;37:5901–12.
Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J. 2021;288:7162–82.
Qin X, Li C, Guo T, et al. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway. J exp clin cancer res:CR. 2017;36:148.
Jiang F, Liu T, He Y, et al. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer. 2011;11:425.
Ansieau S, Bastid J, Doreau A, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79–89.
Mali AV, Joshi AA, Hegde MV, et al. Enterolactone modulates the ERK/NF-kappaB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-beta-induced epithelial-mesenchymal transition. Cancer Biol Med. 2018;15:137–56.
Liu Q, Qiao L, Liang N, et al. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med. 2016;20:1761–9.